Managers / Q4 2023 · view latest →
DSC Advisors, L.P.
CIK 0001299434 · 900 NORTH MICHIGAN AVENUE, SUITE 1600, CHICAGO, IL, 60611 · (312) 915-2485
Summary
Dsc Advisors, L.P. reported $61M in U.S.-listed holdings across 32 positions for Q4 2023.
Its largest position, CVS, represents 19.9% of the portfolio.
Compared with Q3 2023, the fund opened 6 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.1% · $59M
- ETP · 1.5% · $917,200
- Other · 0.4% · $224,400
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NFLXNETFLIX INC | NEW | +585 | 585 | +$284,825 | $284,825 |
| KRANESHARES TR | NEW | +10.0K | 10.0K | +$270,000 | $270,000 |
| INTUINTUIT | NEW | +390 | 390 | +$243,762 | $243,762 |
| PROSHARES TR | NEW | +7.5K | 7.5K | +$224,400 | $224,400 |
| JAMFJAMF HLDG CORP | NEW | +10.0K | 10.0K | +$180,600 | $180,600 |
| MSOSADVISORSHARES TR | NEW | +20.0K | 20.0K | +$140,200 | $140,200 |
| VYNEVYNE THERAPEUTICS INC | ADDED | +581.5K | 696.5K | +$1M | $2M |
| ADTADT INC DEL | ADDED | +45.0K | 75.0K | +$331,500 | $511,500 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CVSCVS HEALTH CORPhistory → | COM | 19.86% | $12M | 152.2K |
| 2 | R1 RCM INC | COM | 16.59% | $10M | 950.0K |
| 3 | BMRNBIOMARIN PHARMACEUTICAL INChistory → | COM | 15.93% | $10M | 100.0K |
| 4 | ZBHZIMMER BIOMET HOLDINGS INChistory → | COM | 14.08% | $9M | 70.0K |
| 5 | ABTABBOTT LABShistory → | COM | 13.25% | $8M | 72.9K |
| 6 | EHTHEHEALTH INChistory → | COM | 5.91% | $4M | 410.0K |
| 7 | VYNEVYNE THERAPEUTICS INChistory → | COM | 2.68% | $2M | 696.5K |
| 8 | GOOGLALPHABET INC | CAP STK CL A | 0.73% | $440,163 | 3.2K |
| 9 | METAMETA PLATFORMS INC | CL A | 0.72% | $433,247 | 1.2K |
| 10 | MSFTMICROSOFT CORP | COM | 0.68% | $414,396 | 1.1K |
| 11 | EHABUSDENHABIT INC | COM | 0.68% | $414,000 | 40.0K |
| 12 | VVISA INC | COM CL A | 0.59% | $356,419 | 1.4K |
| 13 | MAMASTERCARD INCORPORATED | CL A | 0.58% | $349,738 | 820 |
| 14 | CRMSALESFORCE INC | COM | 0.56% | $336,293 | 1.3K |
| 15 | ACNACCENTURE PLC IRELAND | SHS CLASS A | 0.53% | $323,539 | 922 |
| 16 | ADBEADOBE INC | COM | 0.52% | $317,391 | 532 |
| 17 | NFLXNETFLIX INC | COM | 0.47% | $284,825 | 585 |
| 18 | KRANESHARES TR | CSI CHI INTERNET | 0.45% | $270,000 | 10.0K |
| 19 | BRK/BBERKSHIRE HATHAWAY INC DEL | CL B NEW | 0.41% | $250,732 | 703 |
| 20 | INTUINTUIT | COM | 0.40% | $243,762 | 390 |
| 21 | AAPLAPPLE INC | COM | 0.40% | $239,700 | 1.2K |
| 22 | ORCLORACLE CORP | COM | 0.38% | $232,579 | 2.2K |
| 23 | PROSHARES TR | ULTRASHRT S&P500 | 0.37% | $224,400 | 7.5K |
| 24 | JAMFJAMF HLDG CORP | COM | 0.30% | $180,600 | 10.0K |
| 25 | MSOSADVISORSHARES TR | PURE US CANNABIS | 0.23% | $140,200 | 20.0K |
| 26 | GENIGENIUS SPORTS LIMITED | SHARES CL A | 0.10% | $61,800 | 10.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $11M | 19 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $30M | 24 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $63M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $61M | 32 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 33 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $67M | 31 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $115M | 24 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $44M | 17 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $97M | 97 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $100M | 113 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $290M | 132 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $129M | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $98M | 74 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $138M | 74 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $161M | 85 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $121M | 51 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $149M | 49 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $91M | 37 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $102M | 35 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 88 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $506M | 97 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $569M | 85 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $544M | 81 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $826M | 78 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DSCQG PR LLC028-18129
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.